Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A heptapeptide anti-aβ protein aggregation and its application and gene encoding the synthetic polypeptide

A β-protein and heptapeptide technology, applied in the field of heptapeptide and its application and the gene encoding the synthetic polypeptide, can solve problems such as lack of specificity, and achieve the effects of improving memory, improving medical conditions, and major social and economic benefits

Active Publication Date: 2021-05-14
SOUTH CHINA UNIV OF TECH
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the treatment of AD has always lacked effective drugs that are highly specific, relieve and reverse the disease, and improve the prognosis of the disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A heptapeptide anti-aβ protein aggregation and its application and gene encoding the synthetic polypeptide
  • A heptapeptide anti-aβ protein aggregation and its application and gene encoding the synthetic polypeptide
  • A heptapeptide anti-aβ protein aggregation and its application and gene encoding the synthetic polypeptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Synthesis of Peptide WW-7 by Solid Phase Synthesis of Peptide

[0042] 1. Resin selection

[0043] (1) Using the standard Fomc protocol, starting with 0.0125mmol 2-chlorotrityl chloride resin resin (Tianjin Nankai Synthetic Technology Co., Ltd.), according to the amino acid sequence Trp-Asp-Gln-Trp-Cys-Ile-Trp from the C-terminal to the N According to the sequence characteristics of the terminal, 0.3mol of the first Fmoc protected amino acid was added, DCC and 5% (mass fraction) DMAP were added to the reactor to shake the reaction, and the resin was washed with methylpyrrolidone (NMP) to remove excess protected amino acids.

[0044] (2) Using the standard Fomc scheme, initially select 0.0125mmol Wang resin, according to the sequence characteristics of the amino acid sequence Trp-Asp-Gln-Trp-Cys-Ile-Trp from the C-terminal to the N-terminal, add 0.3mol of the first Fmoc protected amino acid , DCC and 5% (mass fraction) DMAP are added to the reactor for shaking reaction,...

Embodiment 2

[0052] Anti-Aβ42 Protein Aggregation Activity Experiment of Polypeptide WW-7 in Vitro

[0053] 1. Experimental method

[0054] Preparation of culture medium: High glucose medium (DMEM), fetal bovine serum (FBS), L-glutamine were prepared according to the mass ratio of 8.75:1:0.25 respectively; 1wt% double antibodies (penicillin and streptomycin) were added at the same time , 0.1 wt% Hygromycin B and 0.05 wt% Blasticidin S antibiotics.

[0055] Preparation of 0.05mM and 0.5mM polypeptide (WW-7) solutions: Weigh 10.4mg of polypeptide WW-7, dissolve it with 10mL of medium, pass through a 0.22μm filter head, the concentration of the mother solution is 1mM, and then use the medium to dissolve The mother liquor was diluted to the concentration required for the experiment.

[0056] Preparation of 1 mg / mL tetracycline solution: Weigh 20 mg of tetracycline, prepare with 10 mL of PBS buffer, pass through a 0.22 μm filter head, and store at -20°C in the dark for future use.

[0057] F...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a heptapeptide against Aβ42 protein aggregation, its application and a gene encoding the synthetic polypeptide. The synthetic polypeptide of the present invention has significant anti-Aβ42 protein aggregation effect, and further has the effect of improving memory and delaying the onset of Alzheimer's disease, and can be widely used in the preparation of anti-Aβ42 protein aggregation drugs or food, or in the preparation of preventive or Drugs or foods for treating Alzheimer's disease can effectively prevent and treat neurodegenerative diseases including AD diseases, improve the medical conditions of neurodegenerative diseases, and have significant social and economic benefits.

Description

technical field [0001] The invention relates to the technical field of polypeptides, in particular to a heptapeptide against Aβ protein aggregation and its application and a gene encoding the synthetic polypeptide. Background technique [0002] Alzheimer's disease (AD), also known as senile dementia, is a central nervous degenerative disease induced by multiple factors. The clinical manifestations of AD are gradual loss of memory, inability to take care of oneself in daily life, incontinence of urine and feces in the late course of the disease, symptoms of mutism, limb stiffness, primitive reflexes such as strong grasping, groping and sucking, and eventually coma and death due to infection and other reasons. The course of AD is about ten years, showing a completely helpless living state from onset to death. The chronic nature of AD, and its assault on the fragile structures that shelter self-knowledge, imposes an enormous emotional and financial burden on the patient, the p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/06C12N15/11A61K38/08A61P25/28A23L33/18
CPCA23V2002/00A61K38/00A23L33/18A61P25/28C07K7/06A23V2200/322A23V2250/55
Inventor 任娇艳杨柳
Owner SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com